Although the association with prior therapies did not reach statistical significance ( P =0.0521), patients with scalp lesions were more frequently managed with rituximab, consistent with therapeutic escalation in more severe or refractory disease.
← all excerpts
Scalp Involvement In Pemphigus: A Retrospective Cohort Study Of Clinical And Immunopathologic Features.
1
0.0521
0.0521